Eur Rev Med Pharmacol Sci 2019; 23 (10): 4333-4340

DOI: 10.26355/eurrev_201905_17939

MicroRNA-488 regulates diabetic nephropathy via TGF-β1 pathway

F. Sun, P.-F. Yu, D. Wang, J. Teng

Department of Nephrology, Yantaishan Hospital, Yantai, China. 2332984998@qq.com


OBJECTIVE: The aim of this study was to clarify the biological roles of microRNA-488 and transforming growth factor β1 (TGF-β1) pathway in the occurrence and progression of diabetic nephropathy (DN).
MATERIALS AND METHODS: Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) was used to detect the expressions of microRNA-488, fibrinogen factors coII, coIIV, and fibronectin (FN) in Human mesangial cells (HMCs) with high-glucose or low-glucose treatment. After transfection of microRNA-488 mimics or inhibitor, expression levels of coII, coIIV, and FN in HMCs were determined by qRT-PCR and Western blot. Their expressions in HMC cells treated with different doses of TGF-β1 at different time points were also detected. Finally, we evaluated the potential influence of microRNA-488 on TGF-β1-induced fibrosis of HMC cells by qRT-PCR.
RESULTS: Compared with low-glucose treatment, the expression of microRNA-488 markedly increased in HMCs treated with high-glucose, as well as coII, coIIV, and FN. Overexpression of microRNA-488 remarkably upregulated mRNA and protein levels of coII, coIIV, and FN, whereas microRNA-488 knockdown downregulated their levels. Expression levels of microRNA-488, coII, coIIV, and FN gradually upregulated with the increase of TGF-β1 dose and treatment duration.
CONCLUSIONS: MicroRNA-488 regulates the development of diabetic nephropathy-induced fibrosis by TGF-β1 pathway.

Free PDF Download

To cite this article

F. Sun, P.-F. Yu, D. Wang, J. Teng
MicroRNA-488 regulates diabetic nephropathy via TGF-β1 pathway

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 10
Pages: 4333-4340
DOI: 10.26355/eurrev_201905_17939